C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
167/191, 530/7.1
C12P 21/02 (2006.01) C07K 14/62 (2006.01) C12N 15/17 (2006.01) C12N 15/81 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1306212
A B S T R A C T Novel rapid-acting human insulin analogues are provided having less tendency to self-association into dimers, tetramers, hexamers, or polymers. The novel human insulin analogues are ormed by substituting one or more of the amino acid residues of human insulin with naturally occuring amino acid residues. The amino acid residue substitutions are preferably more hydrophilic than the natural amino acid residue at the respective position in the molecule. Furthermore, the insulin analogues have the same charge or a greater negative charge at neutral pH than that of human insulin. Preferred amino acid substitutions are Asp, Glu, Ser, Thr, His, and Ile, and more preferred substitutions are Asp and Glu. The novel insulin analogues can be used for the preparation of rapid-acting insulin solutions.
517255
Brange Jens Jorgen Veilgaard
Hansen Mogens Trier
Norris Kjeld
Mccarthy Tetrault Llp
Novo Nordisk A/s
LandOfFree
Insulin analogues and process for their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin analogues and process for their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin analogues and process for their preparation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1296431